Citius Pharmaceuticals, Inc. Convertible Notes Payable
Citius Pharmaceuticals, Inc. (CTXR) had Convertible Notes Payable of $1.69 million as of 2013-12-31, per its 10-KT filed 2014-12-29.
Discontinued › Balance Sheet › Liabilities › Notes Payable
us-gaap:ConvertibleNotesPayable · last filed 2014-12-29
- 2013-12-31: Convertible Notes Payable $1.69M.
| Period end | Convertible Notes Payable |
|---|---|
| 2013-12-31 | $1.69M 10-KT · filed 2014-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |